| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/05/1996 | CN1123663A Composition for curing angicardiopathy and its production and usage |
| 06/05/1996 | CN1031940C Process for preparing substituted pyrrole compounds |
| 06/04/1996 | US5523407 Quinoline derivatives, their production and use as ACAT inhibitors |
| 06/04/1996 | US5523318 Pyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 06/04/1996 | US5523315 N-(hydroxyethyl)butanediamide derivatives |
| 06/04/1996 | US5523314 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
| 06/04/1996 | US5523309 Benzofuran pharmaceutical compounds |
| 06/04/1996 | US5523292 Method of preventing restenosis following coronary angioplasty |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/30/1996 | WO1996016080A1 Human neutrophil elastase inhibitors |
| 05/30/1996 | WO1996016051A1 Hypolipidemic benzothiazepines |
| 05/30/1996 | WO1996016049A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS |
| 05/30/1996 | WO1996016037A1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/30/1996 | WO1996015805A1 Hemoglobin therapy in hemodialysis |
| 05/30/1996 | WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | CA2180529A1 Hemoglobin therapy in hemodialysis |
| 05/29/1996 | EP0713875A1 Sulfonamides |
| 05/29/1996 | EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them |
| 05/29/1996 | EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors |
| 05/29/1996 | EP0713703A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders |
| 05/29/1996 | EP0713653A1 Fortified fruit juice |
| 05/29/1996 | EP0713532A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 05/29/1996 | EP0713483A1 Amidine derivatives with nitric oxide synthetase activities |
| 05/29/1996 | EP0713396A1 Medical use of stem bromelain protease |
| 05/29/1996 | EP0589037B1 Indian derivative and thromboxane antagonist containing the same |
| 05/29/1996 | EP0527748B1 Use of prostaglandin F3alpha as an ocular hypotensive agent |
| 05/29/1996 | EP0521967B1 New use of bambuterol |
| 05/29/1996 | EP0477315B1 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
| 05/29/1996 | CN1123545A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells |
| 05/29/1996 | CN1123276A Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 05/29/1996 | CN1123155A "Xuebaodan"-medicine for nourishing blood and production technology thereof |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521206 Hypotensive agents, treatment of atherosclerosis |
| 05/28/1996 | US5521194 Antiproliferative agent for restenosis treatment |
| 05/28/1996 | US5521191 Method for treatment of arterial stenosis |
| 05/28/1996 | US5521182 1,2,3,4 tetrahydropteridinone cyclic amide derivatives |
| 05/28/1996 | US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome |
| 05/28/1996 | US5521172 Benzothiophene ketones with benzene derivatives |
| 05/28/1996 | US5521170 Benzamide derivatives and pharmaceutical composition comprising the same |
| 05/28/1996 | US5521167 Cyclopentanperhydrophenanthren-17β-(hydroxy or alkoxy)-17α-(Aryl or heterocyclyl)-3β-derivatives active on the cardiovascular system, and pharmaceutical compositions containing same |
| 05/28/1996 | US5521160 Compounds for treatment of atheriosclerosis in blood vessels and prevention of restenosis after angioplasty |
| 05/28/1996 | US5521159 Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments |
| 05/28/1996 | US5521157 Modified polypeptide compound with VIP-like activity |
| 05/28/1996 | US5520912 Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen |
| 05/28/1996 | CA1338352C 2-substituted quinolines |
| 05/26/1996 | CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase |
| 05/25/1996 | CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/24/1996 | CA2163466A1 Fortified fruit juices |
| 05/23/1996 | WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 05/23/1996 | WO1996015128A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 05/23/1996 | WO1996015125A1 Nonpeptide endothelin antagonists |
| 05/23/1996 | WO1996015123A1 Pyridine modulators of acetylcholine receptors |
| 05/23/1996 | WO1996015120A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 05/23/1996 | WO1996015109A1 Endothelin antagonists |
| 05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
| 05/23/1996 | WO1996014846A1 Dihydropyrimidines and uses thereof |
| 05/23/1996 | WO1996014828A1 Hemorrhoidal compositions and method of use |
| 05/23/1996 | WO1996009827A3 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 05/23/1996 | WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 05/23/1996 | CA2202051A1 Nonpeptide endothelin antagonists |
| 05/22/1996 | EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 05/22/1996 | EP0712626A2 Use of R,S-(+/-)-alpha-Lipoic acid, S-(-)-alpha-Lipoic acid in reduced or oxidized form or their metabolites as well as their salts, esters, amides for the manufacture of rheological agents |
| 05/22/1996 | EP0712406A1 Condensed indole derivatives as 5-ht 4-receptor antagonists |
| 05/22/1996 | EP0712402A1 Hydroisoquinoline derivatives |
| 05/22/1996 | EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors |
| 05/22/1996 | EP0712388A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect |
| 05/22/1996 | EP0712303A1 Skin patches and methods for providing testosterone |
| 05/22/1996 | CN1031824C Process for preparing new thiazolidinone and oxazolidinone derivatives |
| 05/21/1996 | US5519138 Angiotensin antagonist |
| 05/21/1996 | US5519042 Method of treating hyperproliferative vascular disease |
| 05/21/1996 | US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/21/1996 | US5519012 Inclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrin |
| 05/21/1996 | US5519006 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 05/21/1996 | CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
| 05/18/1996 | CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 05/17/1996 | WO1996014331A1 Modified neuropeptide y receptors |
| 05/17/1996 | WO1996014328A1 Tumor necrosis factor-gamma |
| 05/17/1996 | WO1996014325A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 05/17/1996 | WO1996014324A1 Smooth muscle cell proliferation inhibitors |
| 05/17/1996 | WO1996014323A1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 05/17/1996 | WO1996014320A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors |
| 05/17/1996 | WO1996014318A1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 05/17/1996 | WO1996014317A1 Novel piperidine derivatives with paf antagonist activity |
| 05/17/1996 | WO1996014307A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 05/17/1996 | WO1996014069A1 Percutaneously absorbable patch |
| 05/17/1996 | CA2204530A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 05/17/1996 | CA2203664A1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity |
| 05/17/1996 | CA2203661A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors |
| 05/15/1996 | EP0711560A1 Pharmaceutical composition for the oral administration of flavonoids |
| 05/15/1996 | EP0711557A1 Base for formulating pharmaceutical agents |
| 05/15/1996 | EP0711556A1 Intravenous solutions containing staurosporine derivatives |
| 05/15/1996 | EP0711343A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 05/15/1996 | EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 05/15/1996 | EP0711286A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity |
| 05/15/1996 | EP0711284A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 05/15/1996 | EP0711272A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists |
| 05/15/1996 | EP0711271A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 05/15/1996 | EP0711172A1 Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
| 05/15/1996 | EP0711162A1 Imidazole 5-position substituted angiotensin ii antagonists |